{
    "nctId": "NCT06310330",
    "briefTitle": "TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography",
    "officialTitle": "Technology Revising Ultrasound Solutions for Tomorrow - Anticancer-treatment Cardiotoxicity Identification by Echocardiography",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasm Malignant Primary",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 250,
    "primaryOutcomeMeasure": "Proportion of patients correctly classified with cancer therapy related cardiac dysfunction (CTRCD)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer and referral for follow-up to identify potential CTRCD\n\nExclusion Criteria:\n\n* Not willing or able to consent",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}